Vir Biotechnology, Inc.
VIR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,000,053 | $1,349,357 | $3,356,277 | $5,438,284 |
| - Cash | $222,947 | $241,576 | $848,631 | $347,815 |
| + Debt | $97,891 | $124,540 | $127,974 | $133,561 |
| Enterprise Value | $874,997 | $1,232,321 | $2,635,620 | $5,224,030 |
| Revenue | $74,205 | $86,180 | $1,615,797 | $1,095,415 |
| % Growth | -13.9% | -94.7% | 47.5% | – |
| Gross Profit | -$404,440 | -$486,647 | $994,830 | $581,544 |
| % Margin | -545% | -564.7% | 61.6% | 53.1% |
| EBITDA | -$508,912 | -$641,637 | $839,851 | $426,562 |
| % Margin | -685.8% | -744.5% | 52% | 38.9% |
| Net Income | -$521,960 | -$615,061 | $515,837 | $528,584 |
| % Margin | -703.4% | -713.7% | 31.9% | 48.3% |
| EPS Diluted | -3.83 | -4.59 | 3.83 | 3.96 |
| % Growth | 16.6% | -219.8% | -3.3% | – |
| Operating Cash Flow | -$446,352 | -$778,785 | $1,663,253 | -$47,589 |
| Capital Expenditures | -$7,301 | -$21,573 | -$68,006 | -$21,817 |
| Free Cash Flow | -$453,653 | -$800,358 | $1,595,247 | -$69,406 |